Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT METFORMIN 850MG TABLET Resolved 2020-10-01 2020-10-22 125455
ACT METFORMIN 850MG TABLET Resolved 2020-04-02 2020-05-14 110649
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-16 2024-09-19 228143
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LAMOTRIGINE 150MG TABLET Discontinued 2025-05-28 2025-05-28 258652
TEVA-LAMOTRIGINE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258646
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258507
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258510
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-29 2025-04-29 256085
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-25 2025-04-25 255824
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Discontinued 2025-05-28 2025-05-28 258625
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
TEVA-LISINOPRIL (TYPE P) 10MG TABLET Discontinued 2019-04-11 2019-04-11 81400
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-LISINOPRIL (TYPE Z) 20MG TABLET Discontinued 2025-05-28 2025-05-28 258694
TEVA-LISINOPRIL (TYPE Z) 5MG TABLET Discontinued 2025-05-28 2025-05-28 258699
TEVA-LISINOPRIL (TYPE Z) 10MG TABLET Discontinued 2019-08-15 2019-08-15 91648
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301